Ann: Release of 2Q23 DroneSentry-C2 Platform Update, page-5

silence on new sales is not golden. A new gun version launched, which might well have held up sales, a software update release, which wouldn't postpone sales, the production has fulfilled the $11m order so they are presumably manufacturing for stock now which shows positivity but of course needs orders eventually. The option exercise at 65c is not a "skin in the game" decision because the company lent the money to the employees on limited recourse, so no capital outlay or risk. The weeks are ticking by, and .........nothing on new significant sales. Its only its modest mkt cap of @$175m that is holding it up, one decent new order can propel it higher. Otherwise, it risks turning into another Alexium, all hype but no follow through and a gradual drift lower. The management claim it retains unique abilities, I'm retaining faith and patience, even occasionally nibbling for more below 30c. Like many here, I've committed in size so it will hurt if the sales promise is unfulfilled.